R Douglas Norby - Net Worth and Insider Trading
R Douglas Norby Net Worth
The estimated net worth of R Douglas Norby is at least $7 Million dollars as of 2024-05-01. R Douglas Norby is the Director of Alexion Pharmaceuticals Inc and owns about 32,481 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. R Douglas Norby is also the Director of Krystal Biotech Inc and owns about 9,000 shares of Krystal Biotech Inc (KRYS) stock worth over $1 Million. Details can be seen in R Douglas Norby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Douglas Norby has not made any transactions after 2018-05-09 and currently still holds the listed stock(s).
Transaction Summary of R Douglas Norby
R Douglas Norby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Douglas Norby owns 5 companies in total, including Krystal Biotech Inc (KRYS) , Alexion Pharmaceuticals Inc (ALXN) , and MagnaChip Semiconductor Corp (MX) among others .
Click here to see the complete history of R Douglas Norby’s form 4 insider trades.
Insider Ownership Summary of R Douglas Norby
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRYS | Krystal Biotech Inc | 2018-05-09 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2017-05-10 | director |
| MX | MagnaChip Semiconductor Corp | 2016-03-11 | director |
| INVN | InvenSense Inc | 2013-09-15 | director |
| NOVT | Novanta Inc | 2009-11-20 | other: Nominee to Board of Directors |
R Douglas Norby Latest Holdings Summary
R Douglas Norby currently owns a total of 2 stocks. Among these stocks, R Douglas Norby owns 32,481 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 11, 2015, with a value of $6 Million and a weighting of 81.14%. R Douglas Norby also owns 9,000 shares of Krystal Biotech Inc (KRYS) as of May 9, 2018, with a value of $1 Million and a weighting of 18.86%.
Latest Holdings of R Douglas Norby
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2015-12-11 | 32,481 | 182.50 | 5,927,783 |
| KRYS | Krystal Biotech Inc | 2018-05-09 | 9,000 | 153.12 | 1,378,080 |
Holding Weightings of R Douglas Norby
R Douglas Norby Form 4 Trading Tracker
According to the SEC Form 4 filings, R Douglas Norby has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 45,442 shares on December 11, 2015, which brought R Douglas Norby around $9 Million.
According to the SEC Form 4 filings, R Douglas Norby has made a total of 0 transactions in Krystal Biotech Inc (KRYS) over the past 5 years. The most-recent trade in Krystal Biotech Inc is the acquisition of 9,000 shares on May 9, 2018, which cost R Douglas Norby around $93,780.
Insider Trading History of R Douglas Norby
- 1
R Douglas Norby Trading Performance
GuruFocus tracks the stock performance after each of R Douglas Norby's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Douglas Norby is 60.1%. GuruFocus also compares R Douglas Norby's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Douglas Norby within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Douglas Norby's insider trading performs compared to the benchmark.
Performance of R Douglas Norby
Average Return
231%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.1 | 60.1 | 123.4 | 231 | 140.87 | 92.12 |
| Relative Return to S&P 500(%) | 35.09 | 54.33 | 120.32 | 224.59 | 136.66 | 75.91 |
R Douglas Norby Ownership Network
Ownership Network List of R Douglas Norby
Ownership Network Relation of R Douglas Norby
R Douglas Norby Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
R Douglas Norby is the director of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .
Krystal Biotech Inc (KRYS) Insider Trades Summary
Over the past 18 months, R Douglas Norby made no insider transaction in Krystal Biotech Inc (KRYS). Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 350,000 shares made by Suma Krishnan , a net sale of 350,000 shares made by Krish S Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .
In summary, during the past 3 months, insiders sold 120,587 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 120,587 shares. During the past 18 months, 954,015 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 954,015 shares.
Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
R Douglas Norby Mailing Address
Above is the net worth, insider trading, and ownership report for R Douglas Norby. You might contact R Douglas Norby via mailing address: C/o Magnachip Semiconductor, Inc., 20400 Stevens Creek Boulevard, Suite 370, Cupertino Ca 95014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
